BioRegenx, Inc.
BRGX
$0.008
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.05M | -4.91M | -7.03M | -4.08M | -3.60M |
| Total Depreciation and Amortization | 2.22M | 1.65M | 1.07M | 203.70K | 4.80K |
| Total Amortization of Deferred Charges | 47.70K | 33.40K | 24.80K | -- | -- |
| Total Other Non-Cash Items | 19.93M | 2.54M | 5.03M | 2.83M | 2.50M |
| Change in Net Operating Assets | 530.60K | 137.60K | 92.40K | -101.00K | -421.60K |
| Cash from Operations | -324.20K | -558.40K | -810.70K | -1.14M | -1.52M |
| Capital Expenditure | -189.40K | -189.40K | -189.40K | -588.40K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 1.40K | 1.40K | 1.40K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -202.10K | -202.10K | -18.65M | -199.40K |
| Cash from Investing | -187.90K | -390.00K | -390.00K | -19.24M | -199.40K |
| Total Debt Issued | 490.30K | 491.40K | 505.80K | 710.50K | 73.80K |
| Total Debt Repaid | -48.30K | -56.20K | -64.20K | -130.20K | -211.70K |
| Issuance of Common Stock | -- | 527.10K | 590.30K | 1.00M | 1.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 18.44M | -- |
| Cash from Financing | 442.10K | 962.40K | 1.03M | 20.03M | 1.20M |
| Foreign Exchange rate Adjustments | 2.90K | -2.00K | 600.00 | 15.00K | 18.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.00K | 12.10K | -168.00K | -335.30K | -491.40K |